Lynette K Rogers Selected Research

Hyperoxia

1/2021	Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation.
1/2021	Glutathione reductase deficiency alters lung development and hyperoxic responses in neonatal mice.
1/2019	Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.
11/2018	Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD.
1/2018	Perinatal inflammation induces sex-related differences in cardiovascular morbidities in mice.
1/2018	Arginase and α-smooth muscle actin induction after hyperoxic exposure in a mouse model of bronchopulmonary dysplasia.
1/2018	Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.
1/2017	miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.
10/2016	Nurr1 expression is modified by inflammation in microglia.
1/2016	Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynette K Rogers Research Topics

Disease

25	Hyperoxia 01/2021 - 03/2002
22	Inflammation (Inflammations) 01/2022 - 10/2007
17	Bronchopulmonary Dysplasia 12/2021 - 11/2009
16	Lung Injury 01/2022 - 09/2002
5	Premature Birth (Birth, Premature) 11/2021 - 01/2014
4	Pulmonary Hypertension 01/2018 - 07/2011
4	Body Weight (Weight, Body) 01/2016 - 09/2002
4	Necrosis 12/2012 - 09/2002
3	Lung Diseases (Lung Disease) 01/2022 - 10/2015
3	Neoplasms (Cancer) 01/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
2	Autism Spectrum Disorder 12/2022 - 11/2017
2	Pulmonary Edema 01/2022 - 03/2002
2	Autistic Disorder (Autism) 01/2022 - 01/2018
2	Infections 10/2019 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2019 - 08/2013
2	Lung Neoplasms (Lung Cancer) 06/2016 - 01/2016
2	Pathologic Constriction (Stenosis) 08/2012 - 12/2011
2	Hyperplasia 08/2012 - 10/2010
1	Acute Lung Injury 01/2022
1	Birth Weight (Birth Weights) 12/2021
1	Bacteremia 12/2021
1	Patent Ductus Arteriosus 12/2021
1	Necrotizing Enterocolitis 12/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2021
1	Asthma (Bronchial Asthma) 08/2021
1	HIV Infections (HIV Infection) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Choriocarcinoma 01/2019
1	Placenta Accreta 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Constipation 01/2018
1	Maternal Obesity 11/2016

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
9	Oxygen (Dioxygen)IBA 12/2021 - 01/2009
9	Docosahexaenoic AcidsIBA 11/2021 - 02/2011
7	ThioredoxinsIBA 01/2021 - 10/2007
7	Oxidants (Oxidizing Agents)IBA 06/2014 - 03/2002
5	AntioxidantsIBA 08/2021 - 12/2008
5	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 10/2019 - 09/2002
5	Aurothioglucose (Gold 50)IBA 01/2019 - 10/2007
4	Glutathione (Reduced Glutathione)IBA 01/2021 - 11/2012
4	Actins (F Actin)IBA 01/2019 - 02/2015
4	Messenger RNA (mRNA)IBA 01/2019 - 02/2011
4	Glutathione Disulfide (GSSG)FDA LinkGeneric 02/2010 - 03/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 01/2018
3	LipopolysaccharidesIBA 01/2022 - 03/2014
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2011
3	Interleukin-6 (Interleukin 6)IBA 11/2021 - 08/2012
3	mouse MIRN29 microRNAIBA 01/2021 - 01/2017
3	Profilins (Profilin)IBA 01/2019 - 01/2016
3	Microfilament Proteins (Actin Binding Proteins)IBA 11/2018 - 01/2016
3	NF-E2-Related Factor 2IBA 01/2018 - 11/2012
3	Thioredoxin-Disulfide ReductaseIBA 01/2016 - 10/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2008 - 03/2002
3	DiquatIBA 12/2006 - 09/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 08/2013
2	Surface-Active Agents (Surfactants)IBA 12/2021 - 04/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2021 - 01/2018
2	ChemokinesIBA 10/2019 - 02/2011
2	ArginaseIBA 01/2018 - 08/2006
2	MethyltransferasesIBA 11/2016 - 10/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 10/2015
2	VimentinIBA 06/2016 - 03/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2015 - 06/2010
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 02/2015 - 07/2011
2	Free RadicalsIBA 06/2014 - 02/2010
2	ProstaglandinsIBA 08/2013 - 02/2010
2	LipidsIBA 08/2012 - 12/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010 - 11/2009
2	Sulfhydryl Compounds (Thiols)IBA 11/2006 - 03/2002
2	Coenzyme A (CoA)IBA 09/2002 - 03/2002
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2022
1	interleukin-18 binding proteinIBA 01/2022
1	Complement System Proteins (Complement)IBA 08/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021
1	Gold CompoundsIBA 04/2021
1	Histones (Histone)IBA 01/2021
1	HaptoglobinsIBA 01/2021
1	CytokinesIBA 10/2019
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2019
1	Inflammation MediatorsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	Progestins (Progestagens)IBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2018
1	polyethylene glycol 3350 (miralax)FDA LinkGeneric 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	HepcidinsIBA 11/2016
1	metal transporting protein 1 (ferroportin)IBA 11/2016
1	Transcription Factors (Transcription Factor)IBA 11/2016
1	IronIBA 11/2016
1	8-Bromo Cyclic Adenosine Monophosphate (8 Bromo Cyclic Adenosine Monophosphate)IBA 06/2016
1	GelsolinIBA 06/2016
1	dimethylargininaseIBA 04/2016
1	Cofilin 1IBA 01/2016
1	quinone (benzoquinone)IBA 01/2016

Therapy/Procedure

7	Therapeutics 08/2021 - 06/2010